Our Inspiration
- Living With Rare Diseases
- Real Stories
  - aHUS
  - gMG
  - HPP
  - LAL-D
  - NMOSD
  - PNH
- Support Services
Albie, one of our guiding stars

When Albie was born, his mom, Charlotte, said that he was “absolutely fine. Everything was fine for about two weeks.”
Our Medicines
- Conditions We Treat
  - aHUS
  - gMG
  - HPP
  - LAL-D
  - NF1 PN
  - NMOSD
  - PNH
- Medicines
- Expanded Access Programs
Our medicines help people like Donnan

As a father of two young children, Donnan recalls being afraid of what the future would hold prior to his diagnosis.
Our Research
We innovate for Ruthie

Married with a newborn son, Ruthie was scared to learn that PNH was a life-threatening illness that at the time had no approved treatment.
Our Commitment
We give back for families like Evie's

At only three months old, Evie's parents were told that her case was severe and that there were no approved or effective treatment options.
Our Company
Roberta is our inspiration

Despite having a constant struggle with symptoms, Roberta revisited her dreams and put herself through nursing school.
Your Career
- Career Opportunities
  - Join Our Team
- Working Here
  - Benefits
  - Culture
Make a difference for families like Tristan's

Tristan's parents experienced a whirlwind of emotions and fear after learning their 5-year-old son had such a rare and serious disease.

LEADERSHIP

Scott Weintraub

SVP, US Commercial Operations and Global Marketing & Commercial Strategy

Scott Weintraub is Senior Vice President, US Commercial Operations and Global Marketing and Commercial Strategy of Alexion, AstraZeneca Rare Disease.

Connect

About Scott

Scott leads US Commercial Operations, heading up an organization of over 900 colleagues across sales, market access, marketing, operations, and patient services. Scott also leads the Global Commercial Strategy function that works cross-functionally within the Global Medicine/Product teams, across regions and functions to help provide commercial strategies for the Alexion portfolio. Scott has over 20 years of commercial experience in the biopharmaceutical industry, including strategic product assessment, brand positioning, commercial life cycle management, business development, analytics, sales, and marketing.

Scott holds a BS in Finance and Marketing from Florida State University and an MBA in Health Administration and Policy from the University of Miami.

Tanner, diagnosed with HPP at 4 days old, with a stuffed animal

My hope for Tanner in the future is that he enters into adulthood. I kind of hope that he will be a doctor, and maybe help kids like doctors have helped him.”

RENÉ, TANNER’S MOM LIVING WITH HPP

HEAR HIS STORY

Scott Weintraub

SVP, US Commercial Operations and Global Marketing & Commercial Strategy

About Scott

You are now leaving www.alexion.com, a website provided by Alexion Pharmaceuticals, Inc. This link will take you to a different site to which this Privacy Policy does not apply.

You are now leaving the alexion.com UK webpage for the global alexion.com website. The content on the global site is intended for a U.S. audience only